Product ID
|
Product name
|
CAS No.
|
Formula
|
Structure
|
A-080840
|
Acebutalol Impurity D
(EP)
1-[5-amino-2-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]ethanone
|
57898-80-3
|
C14H22N2O3
|
 |
A-080860
|
Aciclovir Impurity A
(EP),
Acyclovir Impurity A (EP)
2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl
acetate
|
|
C10H13N5O4
|
 |
A-080823
|
Amoxicillin Impurity C (EP)
Amoxicillin Diketopiperazines
|
|
C16H19N3O5S
|
 |
A-080822
|
Amoxicillin Impurity D (EP)
Amoxicillin Penicilloic acids
|
|
C16H21N3O6S
|
 |
A-080821
|
Amoxicillin Impurity E (EP)
Amoxicillin Penilloic acids
|
178738-48-2
|
C15H21N3O4S
|
 |
A-080850
|
Ampicillin Impurity C
(EP)
Ampicillin Diketopiperazines
|
|
C16H19N3O4S
|
 |
A-080851
|
Ampicillin Impurity F
(EP)
Ampicillin Penilloic acids
|
|
C15H21N3O3S
|
 |
B-080799
|
Azelastin Impurity A
Benzaly diazane (benzohydrazide)
|
613-94-5
|
C7H8N2O
|
 |
B-080800
|
Azelastin Impurity B
1-benzoyl-2-[(4RS)-1-methyl hexahydro-1H-azepin-4yl]diazane
|
|
C14H21N3O
|
 |
C-0808126
|
Azelastin Impurity C
2-[(4-Chloropheyl)acetyl] benzoic acid
|
53242-76-5
|
C15H11Cl3
|
|
C-0808127
|
Azelastin Impurity D
4-(4-Chlorobenzyl)phthalazin-1(2H)-one
|
53242-88-9
|
C15H13ClN2O
|
|
C-0808136
|
Azelastin Impurity E
3-(4-Chlorobenzylidene)isobenzofuran-1(3H)-one
|
20526-97-0
|
C15H9ClO2
|
 |
B-090331
|
Bicalutamide Impurity
Epoxide intermediate
2,3-Epoxy-2-methyl-N-[4-cyano-3-(trifluoromethyl)phenyl] propanamide
|
90357-51-0
|
C12H9F3N2O2
|
 |
B-090332
|
Bicalutamide Impurity
reduction product
N-[4-cyano-3-(trifluoromethyl)pheny1]-3-[(4-fluorophenyl)thio]-2-
hydroxy-2-methylpropanamide
|
|
C17H12F4N2O2S
|
 |
B-070612
|
Bipiperidine
1,4'-Bipiperidine
|
4897-50-1
|
C10H20N2
|
 |
B-070616
|
Boc Hydorxypiperidine
N-Boc-4-Hydroxypiperidine
|
109384-19-2
|
C10H19NO3
|
 |
B-070411
|
Bromo Biphenyl
Carboxylic acid
4'-Bromomethyl-Biphenyl-2-Carboxylic Acid Methyl Ester
|
114772-38-2
|
C15H13BrO2
|
 |
B-070613
|
Butylpiperidine
4-Butylpiperidine
Hydrochloride
|
|
C9H19N.HCl
|
 |
M-021208
|
Captopril Impurity
(MMPA)
3-mercapto-2-methylpropanoic acid (or as
1,2-Diphenylethylamine Salt)
|
26473-47-2
|
C4H8O2S
|
 |
C-02030
|
Captopril disulfide
L-Proline, 1,1'-[dithiobis[(2S)-2-methyl-1-oxo-3,1-propanediyl]]bis-
|
64806-05-9
|
C18H28N2O6S2
|
 |
N-070911
|
Ethyl Nitrobenylidne ester
Ethyl 2-(3-nitrobenzylidene)-3-acetoacetate
|
|
C13H13NO5
|
 |
F-06060
|
Fenofibrate Impurity B
(EP)
Fenofibric Acid
2-[4-(4-Chloro-benzoyl)-phenoxy]-2-methyl propionic acid
|
42017-89-0
|
C17H15ClO4
|
 |
F-051006A
|
USP Fosinopril Related Compound A
(4S)-4-cyclohexyl-[(4-phenylbutyl) phosphinyl]acetyl-L-proline
|
Equivalent
to USP Standard
|
|
F060202G
|
USP Fosinopril Related
Compound G
4-phenylbutyl)phosphinyl acetic acid
(Na free
form)
|
Equivalent to USP
Standard
|
|
F-05110H
|
USP Fosinopril Related Compound H
4-phenylbutylphosphonic
acid
|
Equivalent
to USP Standard
|
|
F060202
|
Fosinopril Impurity
Standard A
Acetic acid, [hydroxy(4-phenylbutyl)phosphinyl]
|
83623-61-4
|
C12H17O4P
|
 |
F-051006
|
'Fosinoprilat'
Fosinopril Impurity
Standard B
L-Proline, 4-cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-,
(4S)
|
95399-71-6
|
C23H34NO5P
|
 |
F-060102
|
Fosinopril Impurity
Standard C
L-Proline, 4-cyclohexyl-, hydrochloride, (4S)
|
90657-55-9
|
C11H19NO2.ClH
|
|
F-060103
|
Fosinopril Impurity
Standard D
Acetic acid,
[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]
|
128948-00-5
|
C19H29O6P
|
 |
F-050601
|
Fosinopril Impurity
Standard F (BHT)
Phenol, 2,6-bis(1,1-dimethylethyl)-4-methyl
|
128-37-0
|
C15H24O
|
 |
F-05110
|
Fosinopril Impurity
Standard G
Phosphonic acid,
(4-phenylbutyl)
|
46348-61-2
|
C10H15O3P
|
 |
F-05111
|
Fosinopril Impurity
Standard H
L-Proline, 4-cyclohexyl-1-(1,3-dioxopentyl)-,
trans
|
149760-14-5
|
C16H25NO4.Mg
|
 |
A-070801
|
Gliclazide Impurity
Azabicyclo[3.3.0]octane.HCl
|
112626-50-3
|
C17H14NCl
|
 |
G052001
|
Glibenclamide Impurity A
(EP),
Glyburide Impurity
Standard A (EP)
Benzamide, N-[2-[4-(aminosulfonyl)phenyl]ethyl]-5-chloro-2-methoxy
|
16673-34-0
|
C16H17ClN2O4S
|
 |
L-05050
|
Lamotrigine
1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)
|
84057-84-1
|
C9H7Cl2N5
|
 |
L-05070
|
Lamotrigine Oxidation
Impurity standard
3-Amino-6-(2,3-dichlorophenyl)1,2,4-triazine-5(4H)-one
|
252186-78-0
|
C9H6Cl2N4O
|
 |
L-040201
|
Lovastatin
Butanoic acid, 2-methyl-,
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl
ester, (2S)
|
75330-75-5
|
C24H36O5
|
 |
T-03120
|
Lovastatin Impurity
(Triol Acid)
1-Naphthaleneheptanoic acid,
1,2,6,7,8,8a-hexahydro-β,δ,8-trihydroxy-2,6-dimethyl-,
(βR,δR,1S,2S,6R,8S,8aR)
|
132748-10-8
|
C19H30O5
|
 |
D-03090
|
Lovastatin Impurity
(Diol Lactone)
2H-Pyran-2-one,
6-[2-[(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthalenyl]ethyl]tetrahydro-4-hydroxy-,
(4R,6R)
|
79952-42-4
|
C19H28O4
|
 |
M-03050
|
Lovastatin Impurity
(Mevinolinic Acid-Sodium
Salt)
[[1S-(1aR*),3a,7b,8b(2S*,4S*),-8ab]-2-Methyl butanoic acid 8(S)-hydroxy-1(S)naphthyl]-3(R),5(R)-dihydroxyheptanoic acid,sodium
|
75225-51-3
|
C24H38O6
|
 |
N-070400
|
Nabumetone Impurity A
4-hydroxy-4-(6-methoxy-2-naphthyl)butan-2-one
|
68427-22-5
|
C15H16O3
|
 |
N-070403
|
Nabumetone Impurity B
6-butyl-2-methoxy naphtalene
|
701270-26-0
|
C15H18O
|
 |
N-070402
|
Nabumetone Impurity C
(EP)
4-(6-methoxy-2-naphthyl)butan-2-ol
|
65726-24-1
|
C15H18O2
|
 |
N-070401
|
Nabumetone Impurity D
(EP),
USP Nabumetone Related
Compound A
4-(6-methoxy-2-naphthyl)but-3-en-2-one, or
1-(6-Methoxy-2-naphthyl)-but-1-en-3-one
|
56600-90-9
|
C15H14O2
|
 |
N-070404
|
Nabumetone Impurity E
4-(6-methoxy-2-naphthyl)butan-2,4-dione
|
98386-82-4
|
C15H14O3
|
 |
P-070607
|
Piperidine acetyl Carobxylic acid
1-Acetyl-4-Piperidinecarboxylic Acid
|
25503-90-6
|
C8H13NO3
|
 |
B-070614
|
Piperidine Methanesulfonyloxy ester
4-Methanesulfonyloxy-piperidine-1-carboxylic acid tert-butyl ester
|
141699-59-4
|
C11H21NO5S
|
 |
B-070501
|
Piperidinyl Benzisoxazole
6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole HCl
|
84163-13-3
|
C12H14ClFN2O
|
 |
P-070502
|
Piperazinyl Benzisothiazole
3-Piperazinyl-1,2-Benzisothiazole Hydrochloride
|
87691-88-1
|
C11H13N3S
|
 |
R-050604
|
Ranitidine.HCl
1,1-Ethenediamine,
N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro
|
66357-35-5
|
C13H22N4O3S
|
 |
R-080317
|
USP Ranitidine Related Compound A
[5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine] hemifumarate
|
91224-69-0
|
C14H22N2O5S
|
 |
R-051208
|
USP Ranitidine Related Compound C,
Rantidine S-oxide
Impurity
1,1-Ethenediamine,
N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N'-methyl-2-nitro
|
73851-70-4
|
C13H22N4O4S
|
 |
R-060107
|
Ranitidine Impurity,
Rantidine N-oxide
1,1-Ethenediamine,
N-[2-[[[5-[(dimethyloxidoamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro
|
73857-20-2
|
C13H22N4O4S
|
 |
S-080603
|
Sumatriptan Succinate Impurity, USP Sumatriptan Related Compound C
[3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt
|
|
C19H29N3O7S
|
 |
T-010100
|
Terbinafine HCl Impurity D (EP)
4-Methylterbinafine HCl
|
|
C22H27N.HCl
|
 |
V-021104
|
Valproic acid
Impurity,
USP Related Compound A
4-Pentenoic acid, 2-(2-propenyl)
|
99-67-2
|
C8H12O2
|
 |
V-021105
|
Valproic acid
Impurity F (EP),
Divalproex Sodium
Impurity
2-Dipropylacetamide, or 2-Propylpentanamide
|
|
C8H17NO
|
 |
|
|
|
|
|